Anterior ischemic optic neuropathy (AION) is a sudden loss of vision caused by interrupted blood flow to the front portion of the optic nerve. It is the most common acute optic nerve disorder in adults over 50, and more than 70% of people first notice the vision loss upon waking up. AION comes in two forms, and the distinction between them matters enormously for both urgency and outcome.
Two Types With Very Different Causes
The non-arteritic form (NAION) is by far the more common type. It results from reduced blood flow through the tiny arteries that feed the optic nerve head, without any underlying blood vessel inflammation. Think of it as a small-vessel circulation problem, similar in concept to a mini-stroke but localized to the nerve that carries visual signals from your eye to your brain.
The arteritic form (AAION) is less common but far more dangerous. It occurs when inflammation inside the walls of those same arteries (a condition called giant cell arteritis) narrows or blocks them entirely. AAION typically strikes people over 70 and can cause severe or total vision loss in the affected eye. Because the same inflammatory process can quickly move to the other eye, AAION is treated as a medical emergency.
What Vision Loss Feels Like
In NAION, vision loss is usually sudden and painless. Most people describe it as blurring or a shadow across part of their visual field, most often the lower half. The hallmark pattern is called an inferior altitudinal defect: you lose the bottom portion of your vision as though a curtain has been pulled halfway up. This pattern, sometimes combined with a blind spot near the center, appears in 55 to 80% of cases. Sharpness of vision varies widely. Between 20 and 33% of people retain normal central acuity, while a similar percentage lose most of it.
Only about 12% of AION patients report eye pain. That’s a useful contrast with optic neuritis, a different condition caused by nerve inflammation rather than blood flow loss. In optic neuritis, more than 92% of patients have pain, especially with eye movement. If your vision dropped suddenly and painlessly, AION is more likely. If it dropped with significant pain, optic neuritis moves higher on the list. Both conditions need prompt evaluation, but the distinction guides what happens next.
AAION tends to cause more severe vision loss, often progressing to near-total or complete blindness in the affected eye. People with the arteritic form frequently also have headaches, scalp tenderness, jaw pain while chewing, fatigue, or unexplained weight loss. These are all signs of the underlying blood vessel inflammation driving the condition.
Why It Happens During Sleep
The optic nerve head gets its blood supply from a ring of small arteries at the back of the eye. Blood flow through these vessels depends on adequate blood pressure pushing blood into them. During sleep, blood pressure naturally dips. For most people this is harmless, but in someone whose optic nerve circulation is already compromised, that nighttime pressure drop can push blood flow below the critical threshold the nerve needs to survive.
A study using 24-hour blood pressure monitoring in 275 patients with optic nerve ischemia confirmed that nocturnal blood pressure drops play a meaningful role. Patients on blood pressure medications showed significantly larger overnight drops in both systolic and diastolic pressure, and those whose visual fields worsened had significantly lower minimum nighttime diastolic readings. This explains the classic presentation: you go to bed seeing normally and wake up with part of your vision missing. The ischemic event likely happens in the hours when blood pressure is at its lowest.
This also explains why some cases seem paradoxical. People being treated for high blood pressure, a condition that raises cardiovascular risk, can actually face higher NAION risk if their medications push nighttime pressure too low. It is not the treatment itself that is harmful, but the mismatch between what the body needs overnight and what the compromised optic nerve can tolerate.
Risk Factors for NAION
NAION is fundamentally a small-vessel disease, so the risk factors mirror those for cardiovascular problems broadly. High blood pressure, diabetes, high cholesterol, and sleep apnea all increase the likelihood. Smoking and atherosclerosis (plaque buildup in arteries) contribute by narrowing the already tiny vessels feeding the optic nerve.
One anatomical factor is particularly important: the size of the optic disc. People with small, crowded optic discs (sometimes called a “disc at risk”) have less room for the nerve fibers passing through the opening in the back of the eye. When even mild swelling occurs from a brief drop in blood flow, the tight space compresses nerve fibers further, worsening the damage. This structural feature is something you’re born with, and it’s one reason NAION can affect people who seem otherwise healthy.
How It Is Diagnosed
An eye doctor can typically identify AION during a dilated eye exam. In the acute phase, the optic disc appears swollen, often in a sectoral pattern (one region more than others), and small flame-shaped hemorrhages may surround it. Over weeks, the swelling resolves and is replaced by pallor as damaged nerve fibers atrophy.
Visual field testing maps exactly which areas of vision are affected, confirming the characteristic altitudinal or arcuate patterns. If AAION is suspected based on age, symptoms, or the severity of vision loss, blood tests check for markers of inflammation. A biopsy of the temporal artery (a small vessel at the temple) can confirm giant cell arteritis definitively.
Treatment and What to Expect
For NAION, there is currently no proven treatment that restores lost vision. The damage from the ischemic event is largely permanent once it occurs. Some mild spontaneous improvement happens in a subset of patients over weeks to months, but significant recovery is uncommon. Management focuses on controlling the underlying risk factors (blood pressure, diabetes, cholesterol, sleep apnea) to protect the other eye. About 15% of people who have NAION in one eye eventually develop it in the other.
AAION is a different story in terms of urgency. Because the arteritic form is driven by active inflammation that can rapidly affect the second eye, treatment with high-dose steroids begins immediately, sometimes before biopsy results are back. International guidelines call for intravenous steroids for three days followed by a prolonged oral taper. The goal is not to reverse damage already done but to prevent catastrophic vision loss in the fellow eye. The speed of treatment initiation directly affects outcomes.
Living With the Vision Changes
Most people with NAION retain enough central vision to read and recognize faces, though the missing portion of the visual field can make navigating stairs, driving, and working at a computer more difficult. Low-vision rehabilitation, including prism glasses and magnification aids, helps many people adapt. Occupational therapists who specialize in vision loss can offer practical strategies for daily tasks.
The psychological impact is often underestimated. Sudden, permanent vision loss in one eye can cause anxiety about the other eye, difficulty with depth perception, and frustration with activities that were previously effortless. Addressing these concerns directly, rather than treating them as secondary to the medical issue, makes a real difference in quality of life after NAION.